Northern Trust’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-2,041,633
| Closed | -$715K | – | 4273 |
|
|
2016
Q3 | $715K | Buy |
2,041,633
+131,185
| +7% | +$45.9K | ﹤0.01% | 3420 |
|
|
2016
Q2 | $891K | Buy |
1,910,448
+165,076
| +9% | +$77K | ﹤0.01% | 3379 |
|
|
2016
Q1 | $2.37M | Buy |
1,745,372
+57,675
| +3% | +$78.4K | ﹤0.01% | 2877 |
|
|
2015
Q4 | $2.48M | Buy |
1,687,697
+32,238
| +2% | +$47.4K | ﹤0.01% | 2920 |
|
|
2015
Q3 | $2.62M | Buy |
1,655,459
+27,676
| +2% | +$43.7K | ﹤0.01% | 2878 |
|
|
2015
Q2 | $2.77M | Buy |
1,627,783
+354,076
| +28% | +$602K | ﹤0.01% | 2887 |
|
|
2015
Q1 | $1.77M | Buy |
1,273,707
+9,381
| +0.7% | +$13K | ﹤0.01% | 3196 |
|
|
2014
Q4 | $1.91M | Sell |
1,264,326
-33,247
| -3% | -$50.2K | ﹤0.01% | 3138 |
|
|
2014
Q3 | $2.67M | Sell |
1,297,573
-6,591
| -0.5% | -$13.6K | ﹤0.01% | 2904 |
|
|
2014
Q2 | $3.99M | Sell |
1,304,164
-39,800
| -3% | -$122K | ﹤0.01% | 2676 |
|
|
2014
Q1 | $3.36M | Sell |
1,343,964
-51,146
| -4% | -$128K | ﹤0.01% | 2818 |
|
|
2013
Q4 | $6.92M | Buy |
1,395,110
+199,104
| +17% | +$988K | ﹤0.01% | 2329 |
|
|
2013
Q3 | $2.73M | Buy |
1,196,006
+791,309
| +196% | +$1.8M | ﹤0.01% | 2907 |
|
|
2013
Q2 | $899K | Buy |
+404,697
| New | +$899K | ﹤0.01% | 3300 |
|
Northern Trust's RXII Position: Q4 2016 in Review
Northern Trust sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 2,041,633 shares — an estimated $715K sold.
Northern Trust first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $6.92M in Q4 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- Northern Trust reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
- Northern Trust sold 2,041,633 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $715K.
- Northern Trust first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
- Northern Trust's GALENA BIOPHARMA INC COM position peaked at $6.92M in Q4 2013.
- 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.
Based on Northern Trust's 13F filing for Q4 2016, filed 13 Feb 2017.